A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome-Reference-Cited by-同舟云学术

A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome

Published:2017-01-11 Issue:10 Volume:31 Page:2011-2019
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kelly A D,Kroeger H,Yamazaki J,Taby R,Neumann F,Yu S,Lee J T,Patel B,Li Y,He R,Liang S,Lu Y,Cesaroni M,Pierce S A,Kornblau S M,Bueso-Ramos C E,Ravandi F,Kantarjian H M,Jelinek J,Issa J-PJ

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/leu201712.pdf

Reference63 articles.

1. Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M et al. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clin Cancer Res 2005; 11: 1416–1424.

2. Breems DA, Van Putten WL, De Greef GE, Van Zelderen-Bhola SL, Gerssen-Schoorl KB, Mellink CH et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008; 26: 4791–4797.

3. Döhner K, Schlenk RF, Habdank M, Scholl C, Rücker FG, Corbacioglu A et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 2005; 106: 3740–3746.

4. Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909–1918.

5. Campbell LJ, Challis J, Fok T, Garson OM . Chromosome 16 abnormalities associated with myeloid malignancies. Genes Chromosomes Cancer 1991; 3: 55–61.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia;Nature Communications;2024-07-07

2. Association between gut microbiota and CpG island methylator phenotype in colorectal cancer;Gut Microbes;2024-06-11

3. Therapeutic targeting of DNA methylation alterations in cancer;Pharmacology & Therapeutics;2024-06

4. Microsatellite instability: A 2024 update;Cancer Science;2024-03-25

5. The pharmacoepigenomic landscape of cancer cell lines reveals the epigenetic component of drug sensitivity;Communications Biology;2023-08-09